BRPI0813832A2 - Métodos para tratamento da ansiedade - Google Patents
Métodos para tratamento da ansiedadeInfo
- Publication number
- BRPI0813832A2 BRPI0813832A2 BRPI0813832-0A2A BRPI0813832A BRPI0813832A2 BR PI0813832 A2 BRPI0813832 A2 BR PI0813832A2 BR PI0813832 A BRPI0813832 A BR PI0813832A BR PI0813832 A2 BRPI0813832 A2 BR PI0813832A2
- Authority
- BR
- Brazil
- Prior art keywords
- treatment methods
- anxiety treatment
- anxiety
- methods
- treatment
- Prior art date
Links
- 208000019901 Anxiety disease Diseases 0.000 title 1
- 230000036506 anxiety Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
- A61P5/22—Drugs for disorders of the endocrine system of the parathyroid hormones for decreasing, blocking or antagonising the activity of calcitonin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Quinoline Compounds (AREA)
- Furan Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US95014407P | 2007-07-17 | 2007-07-17 | |
| PCT/US2008/069428 WO2009012082A1 (en) | 2007-07-17 | 2008-07-08 | Methods for treating anxiety |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0813832A2 true BRPI0813832A2 (pt) | 2015-01-06 |
Family
ID=39810180
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0813832-0A2A BRPI0813832A2 (pt) | 2007-07-17 | 2008-07-08 | Métodos para tratamento da ansiedade |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US8211917B2 (pt) |
| EP (1) | EP2175850B1 (pt) |
| JP (1) | JP2010533720A (pt) |
| KR (1) | KR20100047261A (pt) |
| CN (1) | CN101778628B (pt) |
| AU (1) | AU2008276278A1 (pt) |
| BR (1) | BRPI0813832A2 (pt) |
| CA (1) | CA2693369A1 (pt) |
| ES (1) | ES2621160T3 (pt) |
| NZ (1) | NZ582874A (pt) |
| RU (1) | RU2491931C2 (pt) |
| WO (1) | WO2009012082A1 (pt) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL383715A1 (pl) * | 2005-01-26 | 2008-05-12 | Allergan, Inc. | Amidy kwasu 3-arylo-3-hydroksy-2-amino-propionowego, amidy kwasu 3-heteroarylo-3-hydroksy-2-amino-propionowego i ich związki pokrewne posiadające aktywność przeciwbólową i/lub pobudzającą odporność |
| EP2453890B1 (en) * | 2009-07-17 | 2020-05-27 | Allergan, Inc. | Compositions comprising a cholinesterase inhibitor for treating cognitive disorders |
| BR112012006073A2 (pt) | 2009-09-16 | 2016-05-31 | Allergan Inc | composições e métodos para tratar espasticidade. |
| EP2477623A1 (en) * | 2009-09-16 | 2012-07-25 | Allergan, Inc. | Compositions and methods for treating disorders of gastrointestinal motility |
| JP2013505248A (ja) | 2009-09-16 | 2013-02-14 | アラーガン インコーポレイテッド | 発作性疾患を治療するための組成物及び方法 |
| MX368880B (es) * | 2012-10-15 | 2019-10-21 | Orion Corp | Dexmedetomidina y medetomidina para su uso en el alivio de la aversión al ruido en un animal. |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6071970A (en) * | 1993-02-08 | 2000-06-06 | Nps Pharmaceuticals, Inc. | Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases |
| PT1036065E (pt) * | 1997-12-04 | 2004-09-30 | Allergan Inc | Derivados de imidazol substituidos com actividade do tipo agonista nos receptores alfa 2b ou 2b/2c adrenergicos |
| WO2003045928A1 (en) | 2001-11-26 | 2003-06-05 | Genzyme Corporation | Diastereoselective synthesis of udp-glucose : n-acylsphingosine glucosyltransferase inhibitors |
| NZ544331A (en) * | 2003-07-22 | 2010-03-26 | Arena Pharm Inc | Diaryl and arylheteroaryl urea derivatives as modulators of the 5-HT2A serotonin receptor useful for the prophylaxis and treatment of disorders related thereto |
| CA2552600C (en) * | 2004-01-06 | 2011-08-30 | Taisho Pharmaceutical Co., Ltd. | Triaza-cyclopenta[cd]indene derivatives |
| PL383715A1 (pl) * | 2005-01-26 | 2008-05-12 | Allergan, Inc. | Amidy kwasu 3-arylo-3-hydroksy-2-amino-propionowego, amidy kwasu 3-heteroarylo-3-hydroksy-2-amino-propionowego i ich związki pokrewne posiadające aktywność przeciwbólową i/lub pobudzającą odporność |
| WO2008109287A1 (en) | 2007-03-06 | 2008-09-12 | Allergan, Inc. | Methods for treating cognitive disorders using 1-benzyl-1-hydroxy-2,3-diamino-propyl amines, 3-benzyl-3-hydroxy-2-amino-propionic acid amides and related compounds |
| WO2008109286A1 (en) * | 2007-03-06 | 2008-09-12 | Allergan, Inc. | Methods for treating cognitive disorders using 1-aryl-1-hydroxy-2,3-diamino-propyl amines, 1-heteroaryl-1-hydroxy-2,3-diamino-propyl amines and related compounds |
| WO2008109610A1 (en) | 2007-03-06 | 2008-09-12 | Allergan, Inc. | Methods for treating cognitive disorders using 3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroaryl-3-hydroxy-2-amino-propionic acid amides and related compounds |
| US8173683B2 (en) * | 2007-03-06 | 2012-05-08 | Allergan, Inc. | Methods for treating cognitive disorders |
-
2008
- 2008-07-08 CA CA2693369A patent/CA2693369A1/en not_active Abandoned
- 2008-07-08 RU RU2010105135/15A patent/RU2491931C2/ru not_active IP Right Cessation
- 2008-07-08 CN CN2008801024044A patent/CN101778628B/zh not_active Expired - Fee Related
- 2008-07-08 BR BRPI0813832-0A2A patent/BRPI0813832A2/pt not_active IP Right Cessation
- 2008-07-08 NZ NZ582874A patent/NZ582874A/en not_active IP Right Cessation
- 2008-07-08 US US12/669,304 patent/US8211917B2/en active Active
- 2008-07-08 AU AU2008276278A patent/AU2008276278A1/en not_active Abandoned
- 2008-07-08 WO PCT/US2008/069428 patent/WO2009012082A1/en not_active Ceased
- 2008-07-08 JP JP2010517073A patent/JP2010533720A/ja active Pending
- 2008-07-08 ES ES08781509.8T patent/ES2621160T3/es active Active
- 2008-07-08 EP EP08781509.8A patent/EP2175850B1/en active Active
- 2008-07-08 KR KR1020107003376A patent/KR20100047261A/ko not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| RU2491931C2 (ru) | 2013-09-10 |
| CN101778628B (zh) | 2013-02-06 |
| EP2175850B1 (en) | 2017-01-11 |
| WO2009012082A1 (en) | 2009-01-22 |
| US8211917B2 (en) | 2012-07-03 |
| CN101778628A (zh) | 2010-07-14 |
| ES2621160T3 (es) | 2017-07-03 |
| KR20100047261A (ko) | 2010-05-07 |
| US20100197730A1 (en) | 2010-08-05 |
| EP2175850A1 (en) | 2010-04-21 |
| AU2008276278A1 (en) | 2009-01-22 |
| NZ582874A (en) | 2012-06-29 |
| RU2010105135A (ru) | 2011-08-27 |
| JP2010533720A (ja) | 2010-10-28 |
| CA2693369A1 (en) | 2009-01-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0908260A2 (pt) | Dispositivo para tratamento térmico | |
| BRPI0819076A2 (pt) | aparelho para tratamento de água | |
| BRPI0906748A2 (pt) | Aparelho para tratamento da obesidade | |
| BRPI0817870A2 (pt) | dispositivo para tratamento de aneurisma | |
| BRPI0818056A2 (pt) | Aparelho e métodos para hemodiálise | |
| BRPI0811752A2 (pt) | Aparelho para tratar gás | |
| BRPI0915476A2 (pt) | dispositivo para tratar problemas respiratórios | |
| BRPI0813725A2 (pt) | Métodos e composições para tratamento de doenças | |
| BRPI0908026A2 (pt) | Métodos para o tratamento de doenças do intestino | |
| DE602008004806D1 (de) | Erhitzungsvorrichtung | |
| BRPI0813670A2 (pt) | Compostos para tratamento | |
| PL2190883T3 (pl) | Sposób obróbki biomasy | |
| BRPI0910259A2 (pt) | métodos de tratamento de inflamação | |
| EP2131749A4 (en) | Surgical stapling apparatus | |
| DK2175851T3 (da) | Biofilmbehandling | |
| BRPI0814359A2 (pt) | Método | |
| BRPI0817226A2 (pt) | Método | |
| BRPI0817726A2 (pt) | Método | |
| DK2330887T3 (da) | Behandlingsindretning | |
| BRPI0908715A2 (pt) | métodos para tratamento da psoríase | |
| EP2280672A4 (en) | TEMPORARY OSTOMY DEVICE | |
| BRPI0910854A2 (pt) | métodos de tratamento | |
| DK2361116T3 (da) | Bestrålingsindretning | |
| BRPI0919127A2 (pt) | métodos para tratamento de água | |
| BRPI0922871A2 (pt) | metodos para o tratamento da esclerose múltipla usando pirazinoindóis tetracíclicos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 7A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |